Alkem Laboratories has announced the branding of their active pharmaceutical ingredients (API) business as Alkem Activa, bringing enhanced focus to this growth driver for Alkem. This strategic move underscores the company’s commitment to becoming a formidable global player in the API sector.

Alkem Activa signifies a pivotal move for Mumbai-based Alkem Laboratories as the company is dedicated to producing a diverse range of high-quality APIs that cater to the evolving needs of the pharmaceutical industry.

Moreover, Alkem Activa reflects Alkem’s focus on sustainability and ensures that it remains at the forefront of API innovation through responsible practices. It is poised to introduce numerous APIs, further bolstering the Alkem's robust portfolio. Additionally, Alkem Activa plans to expand its capacity, incorporating cutting-edge technologies like biocatalytic and continuous manufacturing technologies to consolidate its position in this field.

By forging partnerships and collaborations, Alkem Activa aims to become a reliable supplier of high-quality APIs to pharmaceutical companies worldwide, contributing to the global healthcare ecosystem.